SkyWater Announces Participation in Upcoming Investor Conferences
Get Alerts SKYT Hot Sheet
Join SI Premium – FREE
BLOOMINGTON, Minn.--(BUSINESS WIRE)-- SkyWater Technology (NASDAQ: SKYT), the trusted technology realization partner, today announced that company management is scheduled to participate in these upcoming investor conferences in Q2:
Craig-Hallum 20th Annual Institutional Investor Conference
May 31, 2023, at the Depot Renaissance Minneapolis, MN (1x1s only)
Cowen 51st Annual Technology, Media & Telecom Conference
June 1, 2023, at the Lotte Palace New York, NY (1x1s only)
Stifel 2023 Cross Sector Insight Conference
June 6, 2023, at the Intercontinental Boston, MA (webcast presentation at 3:00pm EDT)
Investor presentation material utilized during these events, as well as a live and archived webcast of the Stifel conference presentation, will be made available on the company’s investor relations website at ir.skywatertechnology.com.
About SkyWater Technology
SkyWater (NASDAQ: SKYT) is a U.S.-based semiconductor manufacturer and a DMEA-accredited Category 1A Trusted Foundry. SkyWater’s Technology as a Service model streamlines the path to production for customers with development services, volume production and heterogeneous integration solutions in its world-class U.S. facilities. This pioneering model enables innovators to co-create the next wave of technology with diverse categories including mixed-signal CMOS, ROICs, rad-hard ICs, power management, MEMS, superconducting ICs, photonics, carbon nanotubes and interposers. SkyWater serves growing markets including aerospace & defense, automotive, biomedical, cloud & computing, consumer, industrial and IoT. For more information, visit: www.skywatertechnology.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230517005771/en/
SkyWater Investor Contact: Claire McAdams | [email protected]
SkyWater Media Contact: Lauri Julian | [email protected]
Source: SkyWater Technology
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European
- Esthetics Center Reaches 30-Year Milestone Across 4 Locations
- IT TechPros Celebrates Major Growth Milestone with Official Ribbon Cutting in San Marcos, CA
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Stifel, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share